回头看向前:早期发现神经退行性疾病
Steven T DeKosky1, Kenneth Marek
1Department of Neurology and Alzheimer Disease Research Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. DeKoskyST@upmc.edu
概括
早期检测神经退行性疾病,如阿尔茨海默氏症和帕金森病是成为可能的新分子神经科学工具. 这使得预症状诊断和早期疾病修饰治疗的开发成为可能.
科学领域:
- 神经科学是一个神经科学.
- 医学诊断 医学诊断 医学诊断
- 病理生物学 病理生物学
背景情况:
- 神经退行性疾病,包括阿尔茨海默氏症和帕金森病,进展缓慢.
- 早期检测对于了解疾病机制和改善患者的治疗结果至关重要.
- 当前的诊断和治疗策略通常是在临床症状出现后开始的.
研究的目的:
- 突出分子神经科学近期进展的潜力,以早期检测神经退行性疾病.
- 强调症状前诊断对患者治疗和疾病管理的好处.
- 讨论新兴工具在了解疾病病理生物学中的作用.
主要方法:
- 利用遗传标记来发现疾病倾向.
- 采用先进的神经成像技术进行结构和功能分析.
- 应用生物化学分析来识别疾病特异性生物标志物.
- 整合临床评估以进行全面的患者评估.
主要成果:
- 目前正在进行各种遗传,成像,临床和生化工具的验证研究.
- 这些工具在临床表现之前检测神经退行性疾病方面表现有前途.
- 在识别疾病发病的症状前指标方面取得了进展.
结论:
- 通过分子神经科学的进步,可以实现神经退行性疾病的早期检测.
- 预症状诊断为干预提供了一个关键的窗口.
- 开发用于早期和症状前使用的疾病修饰药物是未来的一个关键目标.
相关概念视频
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Amnesia
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


